Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$305K Buy
991
+75
+8% +$23.3K 0.21% 76
2026
Q2
$256K Sell
916
-61
-6% -$16K 0.17% 88
2026
Q1
$261K Buy
977
+132
+16% +$35.7K 0.24% 81
2025
Q4
$212K Buy
+845
New +$224K 0.2% 87

Other funds holding LH

Lawood & Co's LH Position: Q3 2026 in Review

Lawood & Co increased its Labcorp (LH) stake by 8.2% in Q3 2026, buying an estimated $23.3K and bringing the position to 991 shares worth $305K. The position accounts for 0.21% of the portfolio, ranked #76.

Lawood & Co first reported a position in LH in Q4 2025 and has held it in 4 quarters since. 32 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Lawood & Co held 991 shares of Labcorp worth $305K as of Q3 2026.
  • Lawood & Co bought 75 Labcorp shares in Q3 2026, an estimated $23.3K.
  • Labcorp made up 0.21% of Lawood & Co's portfolio in Q3 2026, its #76 holding.
  • Lawood & Co first reported a position in Labcorp in Q4 2025 and has held it in 4 quarters since.
  • 32 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Lawood & Co's 13F filing for Q3 2026, filed 9 Oct 2026.